Over 100 small biotech CEOs blast Pelosi's drug pricing bill

Over 100 small biotech CEOs blast Pelosi's drug pricing bill

STAT Plus: More than 100 small biotech CEOs sound off against Pelosi’s signature drug pricing bill

By NICHOLAS FLORKO

BRENDAN SMIALOWSKI/AFP VIA GETTY IMAGES

In a new letter shared exclusively with STAT, nearly 150 biotech CEOs are calling on Congress to abandon Speaker Nancy Pelosi's drug pricing bill.

READ MORE